SynBioBeta Speaker
Kang Kang
LinkZill
Partner & CBO
Dr. Kang Kang, Partner and Chief Bioinformatics Officer at LinkZill. He received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong. He previously worked at BGI Research Institute, the Leibniz Association in Germany, the Novo Nordisk Center for Biosustainability at the Technical University of Denmark, and several biotechnology startups. He possesses 16 years of experience in the R&D and commercialization of synthetic biology, bioinformatics, high-throughput biotechnology, and life sciences instruments. Currently, at LinkZill, he oversees technology, product, and application development for semiconductor-based life sciences tools, including the high-throughput DNA synthesizer powered by thin-film transistor (TFT) technology.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Kang
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
